Study Showed Patients Using COPAXONE® Had Significantly Lower Risk of Relapse and Lower Medical Costs Compared to Patients Using Rebif® in Relapsing-Remitting Multiple Sclerosis (RRMS)... more »
|
|||||
|
Multiple Sclerosis Info
Search
This Month
|
Sunday, October 28
COPAXONE® Had Significantly Lower Risk of Relapse than Patients Using Rebif®
by
All About MS
on Sun 28 Oct 2007 12:00 AM CST
|
||||